| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
20,793 |
19,035 |
$1.45M |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
16,043 |
14,881 |
$758K |
| S0302 |
Completed early periodic screening diagnosis and treatment (epsdt) service (list in addition to code for appropriate evaluation and management service) |
3,650 |
3,617 |
$210K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
1,433 |
1,397 |
$125K |
| 77067 |
Screening mammography, bilateral, including computer-aided detection |
1,867 |
1,807 |
$105K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
7,086 |
6,939 |
$81K |
| 36415 |
Collection of venous blood by venipuncture |
20,162 |
18,699 |
$80K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
757 |
752 |
$51K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
558 |
555 |
$41K |
| 99396 |
Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years |
426 |
423 |
$40K |
| 80061 |
Lipid panel |
3,398 |
3,344 |
$39K |
| 99395 |
Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years |
398 |
395 |
$33K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
3,559 |
3,503 |
$29K |
| 90472 |
Immunization administration, each additional vaccine (list separately) |
2,065 |
2,033 |
$28K |
| 92004 |
Ophthalmological services: medical examination and evaluation, comprehensive, new patient |
451 |
441 |
$26K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
284 |
283 |
$24K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
367 |
356 |
$24K |
| 92014 |
Ophthalmological services: medical examination and evaluation, comprehensive, established patient |
595 |
569 |
$24K |
| 84443 |
Thyroid stimulating hormone (TSH) |
1,471 |
1,449 |
$20K |
| 80053 |
Comprehensive metabolic panel |
2,131 |
2,027 |
$19K |
| G0108 |
Diabetes outpatient self-management training services, individual, per 30 minutes |
414 |
326 |
$18K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
616 |
611 |
$17K |
| 99215 |
Prolong outpt/office vis |
143 |
141 |
$17K |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
707 |
695 |
$17K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
2,779 |
2,607 |
$17K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
2,169 |
2,044 |
$15K |
| 0002A |
|
1,051 |
954 |
$15K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
447 |
439 |
$14K |
| 80050 |
General health panel |
279 |
273 |
$14K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
438 |
430 |
$14K |
| 90686 |
|
2,535 |
2,492 |
$14K |
| 92340 |
Fitting of spectacles, except for aphakia; monofocal |
776 |
766 |
$13K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
476 |
451 |
$12K |
| 92551 |
|
2,041 |
2,026 |
$12K |
| 0001A |
|
1,121 |
1,003 |
$12K |
| 96127 |
|
2,833 |
2,786 |
$11K |
| 87389 |
Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies |
511 |
504 |
$11K |
| 99188 |
|
1,308 |
1,300 |
$10K |
| 86803 |
|
627 |
621 |
$9K |
| 92015 |
Determination of refractive state |
1,158 |
1,122 |
$7K |
| 90682 |
|
210 |
204 |
$7K |
| 87624 |
Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types |
196 |
196 |
$7K |
| 85027 |
|
1,031 |
955 |
$6K |
| X5622 |
|
928 |
919 |
$6K |
| 91320 |
|
64 |
63 |
$6K |
| G0145 |
Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, with screening by automated system and manual rescreening under physician supervision |
237 |
231 |
$6K |
| 0054A |
|
137 |
136 |
$6K |
| 90651 |
|
214 |
210 |
$5K |
| 99000 |
|
405 |
399 |
$5K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
904 |
824 |
$5K |
| 92341 |
|
300 |
291 |
$5K |
| 90715 |
|
317 |
312 |
$4K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
471 |
456 |
$4K |
| 77063 |
Screening digital breast tomosynthesis, bilateral |
200 |
200 |
$4K |
| 82728 |
|
276 |
274 |
$4K |
| 90480 |
|
107 |
106 |
$3K |
| 90670 |
|
358 |
352 |
$3K |
| G0179 |
Physician or allowed practitioner re-certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and allowed practitioners to affirm the initial implementation of the plan of care |
174 |
165 |
$3K |
| 99173 |
|
2,184 |
2,171 |
$2K |
| 0064A |
|
71 |
70 |
$2K |
| 81001 |
|
950 |
907 |
$2K |
| 99442 |
|
108 |
66 |
$2K |
| 87210 |
|
455 |
439 |
$2K |
| 90662 |
|
48 |
47 |
$2K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
109 |
107 |
$2K |
| 0004A |
|
69 |
68 |
$2K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
46 |
46 |
$2K |
| 82043 |
|
358 |
355 |
$2K |
| 0071A |
|
47 |
47 |
$2K |
| 99243 |
|
113 |
106 |
$2K |
| 73630 |
|
68 |
51 |
$1K |
| 87081 |
|
302 |
289 |
$1K |
| G0008 |
Administration of influenza virus vaccine |
229 |
204 |
$1K |
| 85610 |
|
267 |
161 |
$1K |
| 81025 |
|
116 |
116 |
$968.06 |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
121 |
114 |
$958.32 |
| 84439 |
|
111 |
110 |
$946.93 |
| G2211 |
Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) |
574 |
552 |
$917.35 |
| 0124A |
|
27 |
25 |
$873.17 |
| 82607 |
|
58 |
58 |
$801.87 |
| 99460 |
|
12 |
12 |
$780.18 |
| 99441 |
|
72 |
44 |
$752.60 |
| 36416 |
|
262 |
191 |
$714.03 |
| 0072A |
|
16 |
16 |
$654.30 |
| 86140 |
|
137 |
131 |
$649.19 |
| V5266 |
Battery for use in hearing device |
25 |
25 |
$637.00 |
| 82947 |
|
178 |
174 |
$622.76 |
| 85018 |
|
309 |
303 |
$617.41 |
| 90734 |
|
205 |
201 |
$595.57 |
| 83550 |
|
69 |
69 |
$583.33 |
| 99238 |
Hospital discharge day management, 30 minutes or less |
13 |
12 |
$557.48 |
| 77080 |
|
26 |
25 |
$541.39 |
| 90656 |
|
116 |
116 |
$541.13 |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
12 |
12 |
$461.44 |
| 99443 |
|
22 |
14 |
$444.72 |
| 92567 |
|
120 |
118 |
$414.96 |
| 85652 |
|
168 |
164 |
$390.14 |
| 86780 |
|
27 |
27 |
$369.04 |
| 83655 |
|
30 |
25 |
$360.96 |
| 93000 |
|
36 |
36 |
$335.72 |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
85 |
80 |
$331.43 |
| G0103 |
Prostate cancer screening; prostate specific antigen test (psa) |
12 |
12 |
$217.54 |
| 80076 |
|
28 |
27 |
$211.55 |
| 71046 |
Radiologic examination, chest; 2 views |
25 |
24 |
$174.26 |
| 81003 |
|
136 |
130 |
$134.79 |
| 83540 |
|
15 |
15 |
$85.64 |
| 87186 |
|
13 |
12 |
$62.86 |
| 99421 |
|
82 |
75 |
$34.68 |
| 84703 |
|
97 |
86 |
$9.83 |
| 90698 |
|
83 |
83 |
$0.00 |
| 90696 |
|
12 |
12 |
$0.00 |
| 90697 |
|
26 |
25 |
$0.00 |
| 90680 |
|
26 |
25 |
$0.00 |
| 90677 |
|
31 |
30 |
$0.00 |
| 90744 |
|
13 |
13 |
$0.00 |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
113 |
106 |
$0.00 |
| 90633 |
|
126 |
123 |
$0.00 |
| 99244 |
Office or other outpatient consultation, moderate to high complexity |
41 |
39 |
$0.00 |
| 90685 |
|
43 |
43 |
$0.00 |
| 91300 |
|
97 |
90 |
$0.00 |
| 92012 |
Ophthalmological services: medical examination and evaluation, intermediate, established patient |
18 |
13 |
$0.00 |
| G0476 |
Infectious agent detection by nucleic acid (dna or rna); human papillomavirus (hpv), high-risk types (e.g., 16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 68) for cervical cancer screening, must be performed in addition to pap test |
12 |
12 |
$0.00 |